Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Circulation|November 28, 2001
Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injuryL Wu, M Iwai, H Nakagami, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2000
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21S Hayashi, R Morishita, H Matsushita, et al.
Circulation|September 12, 2000
Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular diseaseK Yamamoto, R Morishita, N Tomita, et al.
Circulation|March 29, 2000
Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cellsH Matsushita, R Morishita, M Aoki, et al.
Hypertension (Dallas, Tex. : 1979)|May 23, 2001
Contribution of Bcl-2, but not Bcl-xL and Bax, to antiapoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothelial cellsK Yamamoto, R Morishita, S Hayashi, et al.
Gene Therapy|April 21, 2001
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial diseaseY Taniyama, R Morishita, M Aoki, et al.
Journal of Hypertension|November 1, 2000
Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cellsH Nakagami, R Morishita, K Yamamoto, et al.
Circulation|November 7, 2001
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetesY Taniyama, R Morishita, K Hiraoka, et al.
Circulation|July 13, 2000
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamstersY Taniyama, R Morishita, H Nakagami, et al.
Gene Therapy|March 3, 2006
NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclastsH Shimizu, H Nakagami, I Tsukamoto, et al.
Pageof 4